FibroBiologics wins new US patent covering topical fibroblast-based wound healing therapy - FBLG News | RalliesFibroBiologics wins new US patent covering topical fibroblast-based wound healing therapy
F
FBLG• New US patent covers topical fibroblast wound-healing therapy
- FibroBiologics received U.S. Patent No. 12,721,866 covering topical use of 3D spheroid fibroblasts for wound healing.
- Claims cover methods to treat or speed healing in chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers.
- Patent also covers fibroblast-derived materials such as extracellular vesicles and exosomes for topical wound treatment.
- Issued Sept. 1, 2026, extending the company’s fibroblast-focused intellectual property portfolio beyond 270 issued and pending patents.
